TrianglePUBLICATIONS · 22394596
Identification of an active, well-tolerated dose of pralatrexate in patients with relapsed or refractory cutaneous T-cell lymphoma.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Blood
- Publication date
- 2012 May 3
- First author
- Horwitz SM
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Horwitz SM
- type
- Author
- name
- Kim YH
- type
- Author
- name
- Foss F
- type
- Author
- name
- Zain JM
- type
- Author
- name
- Myskowski PL
- type
- Author
- name
- Lechowicz MJ
- type
- Author
- name
- Fisher DC
- type
- Author
- name
- Shustov AR
- type
- Author
- name
- Bartlett NL
- type
- Author
- name
- Delioukina ML
- type
- Author
- name
- Koutsoukos T
- type
- Author
- name
- Saunders ME
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Horwitz SM
- type
- Author
- name
- Kim YH
- type
- Author
- name
- Foss F
- type
- Author
- name
- Zain JM
- type
- Author
- name
- Myskowski PL
- type
- Author
- name
- Lechowicz MJ
- type
- Author
- name
- Fisher DC
- type
- Author
- name
- Shustov AR
- type
- Author
- name
- Bartlett NL
- type
- Author
- name
- Delioukina ML
- type
- Author
- name
- Koutsoukos T
- type
- Author
- name
- Saunders ME
- type
- Author
- bibliography ids
- nci-bib-8b59b456aa893ee983d9fe58
- book metadata
- content sha256
- e0b570191be1e01a87a69224bff556e71b1e65090245bfb5e477c297fd631ece
- document type
- citation
- dois
- 10.1182/blood-2011-11-390211
- electronic publication date
- display
- 2012 Mar 6
- precision
- day
- year
- 2012
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:22394596
- immutable id
- pubmed:22394596@e0b570191be1e01a87a69224bff556e71b1e65090245bfb5e477c297fd631ece
- journal
- abbreviation
- Blood
- issn electronic
- 1528-0020
- issn print
- 0006-4971
- issue
- 18
- name
- Blood
- nlm unique id
- 7603509
- pages
- 4115-22
- volume
- 119
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 22394596
- provenance
- batch id
- c95be1d0b8cf19942816
- provider
- NCBI PubMed ESummary
- record sha256
- 23f56ad324d4c7505d88aea5efef656394d851da31dba11a95ce66ef16c8cd58
- response sha256
- a96bb680a8f3690267e009557d1b07aab71455ba44aeba18695d98a3eeb5fcf2
- retrieved at
- 2026-09-09T23:46:47.691937+00:00
- publication date
- display
- 2012 May 3
- precision
- day
- year
- 2012
- publication types
- Clinical Trial, Phase I
- Clinical Trial, Phase II
- Comparative Study
- Journal Article
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Identification of an active, well-tolerated dose of pralatrexate in patients with relapsed or refractory cutaneous T-cell lymphoma.
Preserved source evidence · Not medical advice